Clinical outcomes
| All patients (n = 59) | ADAPT only (n = 46) | ADAPT with solumbra salvage (n = 13) | p-value | |
|---|---|---|---|---|
| Symptomatic intraparenchymal hemorrhage | 1.7% | 2.2% | 0 | 1 |
| Symptomatic subarachnoid h | 1.7% | 0 | 7.7% | 0.22 |
| Neuro-ICU length of stay, days | 3.1 | 2.6 | 4.6 | 0.11 |
| Hospital length of stay, days | 6.6 | 6.2 | 8 | 0.22 |
| Discharge to home: | 22% | 26% | 8% | 0.26 |
| In-Hospital Mortality / Discharge to Hospice | 14% | 9% | 31% | 0.06 |
| 90 day Mortality | 17% | 11% | 39% | 0.033 |
| 90 day mRS 4–6 | 36% | 28% | 62% | 0.047 |
| 90 day mRS 0–2 | 49% | 54% | 31% | 0.21 |